High5 with Dr. Igor Grant, MD
High5 with Dr. Igor Grant, MD
Podcast Description
Welcome to High5 with Dr. Igor Grant, Distinguished Professor of Psychiatry and Director of the Center for Medicinal Cannabis Research at UC San Diego. Each month, we’ll take you on a fascinating journey into the evolving world of medicinal cannabis. From groundbreaking research to candid conversations with top scientists and clinicians across the globe. In each episode, Dr. Grant poses five thought-provoking questions to his guest, uncovering their personal journey and unique contributions to the field of medicinal cannabis.
Podcast Insights
Content Themes
The podcast delves into various topics surrounding medicinal cannabis, including its impact on pain management, the role of neuroimaging in understanding substance use, and cardiovascular risks associated with cannabis use, with specific episodes discussing the Cannabis Act in Canada and its implications for the U.S. as well as the relationship between cannabis and driving impairment.

Welcome to High5 with Dr. Igor Grant, Distinguished Professor of Psychiatry and Director of the Center for Medicinal Cannabis Research (CMCR) at UC San Diego. Each month, we’ll take you on a fascinating journey into the evolving world of medicinal cannabis. From groundbreaking research to candid conversations with top scientists and clinicians across the globe. In each episode, Dr. Grant poses five thought-provoking questions to his guest, uncovering their personal journey and unique contributions to the field of medicinal cannabis.
In this episode, Dr. Alexandros Makriyannis discusses how understanding the body’s cannabinoid receptors can guide the development of new medicines for pain, obesity, and addiction. He explains how different compounds activate or block CB1 and CB2 receptors, and how mapping their three-dimensional structures helps researchers design more selective treatments. The conversation explores CB1 neutral antagonists, which aim to retain therapeutic benefits while avoiding side effects associated with earlier drugs, and CB2 agonists being investigated for inflammation and pain. He also describes findings in mice showing that blocking CB1 reduced a measure of fentanyl reward without diminishing its pain-relieving effects, while emphasizing the need for human studies. Emerging directions include comparisons with GLP-1 therapies and compounds that combine CB2 activation with CB1 blockade. A central message is that precisely targeting the endocannabinoid system may offer new treatments with fewer unwanted effects.
Chapters
00:03 Combating Opioid Addiction with Cannabinoids
01:14 New chapter
01:15 Introduction to Cannabinoid Science
03:08 Understanding Cannabinoid Receptors
05:45 The Role of THC and Synthetic Cannabinoids
08:28 Exploring CB2 Receptors and Their Functions
11:15 Developing CB2 Agonists for Pain Management
13:43 Neutral Antagonists and Their Potential
16:31 The Future of Cannabinoid Research
19:15 The Importance of Structure in Drug Development
21:55 Combating Opioid Addiction with Cannabinoids
24:37 The Intersection of Cannabinoids and Obesity Treatments
27:05 Promising Cannabinoid-Based Treatments
29:54 Conclusion and Future Directions

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.